Skip to main content

Peer Review reports

From: Neoadjuvant therapy of BRCA1-driven ovarian cancer by combination of cisplatin, mitomycin C and doxorubicin

Original Submission
15 Jan 2021 Submitted Original manuscript
21 Jan 2021 Reviewed Reviewer Report - Marek Szwiec
22 Jan 2021 Reviewed Reviewer Report - Arvids Irmejs
24 Jan 2021 Author responded Author comments - Tatiana Gorodnova
Resubmission - Version 2
24 Jan 2021 Submitted Manuscript version 2
25 Jan 2021 Reviewed Reviewer Report - Marek Szwiec
25 Jan 2021 Reviewed Reviewer Report - Arvids Irmejs
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
27 Jan 2021 Editorially accepted
3 Feb 2021 Article published 10.1186/s13053-021-00173-2

You can find further information about peer review here.

Back to article page